Navigation Links
Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
Date:2/29/2008

CINCINNATI, Feb. 29 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that Vice President and Chief Marketing Officer Simon Higginbotham will participate in the 29th Annual Raymond James Institutional Investors Conference. The conference will be held at the Hyatt Regency Grand Cypress in Orlando, March 2-5, 2008. Kendle's presentation is scheduled for Wednesday, March 5 at 1:40 p.m. Eastern Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events section) or at http://www.wsw.com/webcast/rj33/kndl/. An archived version can be accessed following Kendle's presentation and will be available through April 4. Slides accompanying the presentation will be available by 9 a.m. Eastern Time on March 5 at http://www.kendle.com in the Investor Relations section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
2. Kendle to Present at the Wachovia 2008 Healthcare Conference
3. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
4. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
5. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle to Present at the UBS Global Life Sciences Conference
8. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
9. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
11. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Diego, CA (PRWEB) , ... January 24, 2017 ... ... the development of label-free graphene biosensor assays for fragment-based screening, will ... at the 2017 Society for Laboratory Automation and Screening (SLAS) conference in Washington, ...
(Date:1/24/2017)... ... January 23, 2017 , ... Edward ... first-ever recipient of the National Academy of Sciences Prize in Food and Agriculture ... nutrition. , The annual National Academy of Sciences (NAS) Prize in Food and ...
(Date:1/24/2017)... , Jan. 23, 2017  Today, the Fisher Center ... have funded an important study that could lead to ... onset of Alzheimer,s disease. This groundbreaking research was conducted ... led by Nobel Laureate Dr. Paul Greengard , ... disease. Fisher Center scientists have linked a ...
(Date:1/23/2017)... Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today ... based Phase 1 trial with severe kidney ... reducing inflamed protein biomarkers in patients with severe kidney ... this is the first time in medical history that ... between epigenetic regulation and its potential for positive disease ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017 MedNet ... that supports the entire spectrum of clinical research, ... another record-breaking year for the organization in terms ... in MedNet,s eClinical products and services. The company,s ... marketplace success of iMedNet ...
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
(Date:1/4/2017)...  For the thousands of attendees at this year,s International Consumer Electronics ... and biometric measurement devices and services, will be featuring its new line ... A&D Medical,s special CES Exhibit Suite , the new upper arm ... company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):